Cargando…

Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany

Treatment persistence poses a crucial criterion for therapeutic success. Like in many other chronic diseases, in overactive bladder (OAB) syndrome also, many patients discontinue their treatment for diverse reasons. In order to evaluate the persistence in medication, this paper presents data of prop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murgas, Sandra, Adolf, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342142/ https://www.ncbi.nlm.nih.gov/pubmed/30697533 http://dx.doi.org/10.2147/RRU.S185278

Ejemplares similares

Efficacy and Safety of Propiverine in Children with Overactive Bladder
por: Kim, Woo Jung, et al.
Publicado: (2012)

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine
por: Müderrisoglu, A. Elif, et al.
Publicado: (2022)

Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting
por: Amiri, Marjan, et al.
Publicado: (2021)

Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study
por: Ivchenko, A., et al.
Publicado: (2018)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Brain penetration of the OAB drug trospium chloride is not increased in aged mice
por: Kranz, Jasmin, et al.
Publicado: (2011)

Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
por: Guay, David RP
Publicado: (2005)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

New Stability-Indicating RP-UFLC Method for Determination of Trospium Chloride in Tablet Dosage Form
por: Panda, Sagar Suman, et al.
Publicado: (2012)

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation
por: Oh, Jun Hyung, et al.
Publicado: (2010)

Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023)

Propiverine Hydrochloride as a Treatment for Fecal Incontinence
por: Irei, Yasue, et al.
Publicado: (2020)

Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study
por: Oelke, Matthias, et al.
Publicado: (2011)

Effect of Concomitant Administration of Trospium Chloride Extended Release on the Steady-State Pharmacokinetics of Metformin in Healthy Adults
por: Oefelein, Michael G., et al.
Publicado: (2013)

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

Drugs for the overactive bladder: are there differences in persistence and compliance?
por: Andersson, Karl-Erik
Publicado: (2017)

Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience
por: Allison, Sara J., et al.
Publicado: (2018)

Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patients
por: Müderrisoglu, A. Elif, et al.
Publicado: (2023)

Persistence and compliance with medication management in the treatment of overactive bladder
por: Kim, Tae Heon, et al.
Publicado: (2016)

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder
por: Zhong, Hui, et al.
Publicado: (2022)

Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder
por: Dmochowski, Roger R., et al.
Publicado: (2023)

Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study
por: Srivastava, Vinit Kumar, et al.
Publicado: (2020)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Comparision effects of solifenacin, darifenacin, propiverine on ocular parameters in eyes: A prospective study
por: Ölçücü, Mahmut Taha, et al.
Publicado: (2020)

OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice
por: Hamid, Rizwan, et al.
Publicado: (2020)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Effectiveness of antimuscarinics and a beta-3 adrenoceptor agonist in patients with overactive bladder in a real-world setting
por: Huang, Chiung-Kun, et al.
Publicado: (2020)

Real-life patient experiences of TTNS in the treatment of overactive bladder syndrome
por: te Dorsthorst, Manon, et al.
Publicado: (2021)

Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data
por: Andretta, Elena, et al.
Publicado: (2022)

Pumpkin Seed Oil Extracted From Cucurbita maxima Improves Urinary Disorder in Human Overactive Bladder
por: Nishimura, Mie, et al.
Publicado: (2014)

The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum
por: Wuest, Melinda, et al.
Publicado: (2011)

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin
por: Tijnagel, Marloes J., et al.
Publicado: (2017)

Prevalence, evaluation and management of overactive bladder in primary care
por: Cheung, Wellman W, et al.
Publicado: (2009)

Evaluation and management of overactive bladder: strategies for optimizing care
por: Willis-Gray, Marcella G, et al.
Publicado: (2016)

Evaluation of autonomic function in children and adolescents with overactive bladder
por: Gondim, Rhaiana, et al.
Publicado: (2021)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ikak4pa67coef8c6jolk2h33ni